ARCHIVES

IDMC Halts Mekinist-Tafinlar Trial Early Due to OS Benefit; Recommends Crossover

This article is from The Cancer Letter archive.

Vol. 37 No. 7 | July 25, 2014

Download PDF Visit The Full Archive

Related Articles

Leyland-Jones Named Director of Emory’s Winship Cancer Institute

November 17, 2006

Ronald DePinho Apologizes, Takes Responsibility For “Morale Issues” at MD Anderson

September 27, 2013

In Brief: Schwarzkopf In NCCS TV Spot; AACI elects Officers; Nobel Prize In Medicine awarded

October 18, 1996

FDA Approves Ribavirin Phase 102 Trials

October 30, 1987

Cancer Prevention: HHS Calls for Warning Labels on Cigars, Says Teen Use High

March 5, 1999

NCI Cooperative Group, Cancer Center Trials Listed

June 27, 2008